NewSquare Capital’s Ocugen OCGN Stock Holding History

NewSquare Capital’s Portfolio OCGN Stock Details OCGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-50	Closed	-$27	–	802
2023 Q2	$27	Hold	50	–	–	﹤0.01%	833
2023 Q1	$43	Hold	50	–	–	﹤0.01%	852
2022 Q4	$65	Buy	+50	New	+$78	﹤0.01%	788

Other funds holding OCGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

NewSquare Capital's OCGN Position: Q3 2023 in Review

NewSquare Capital sold out of Ocugen (OCGN) in Q3 2023, closing a stake of 50 shares — an estimated $27 sold.

NewSquare Capital first reported a position in OCGN in Q4 2022 and held it in 3 quarters. The position peaked at $65 in Q4 2022. 78 funds tracked by Wall St. Rank hold OCGN as of Q3 2023.

NewSquare Capital reported no remaining Ocugen position as of Q3 2023 after selling out during the quarter.
NewSquare Capital sold 50 Ocugen shares in Q3 2023, an estimated $27.
NewSquare Capital first reported a position in Ocugen in Q4 2022 and held it in 3 quarters.
NewSquare Capital's Ocugen position peaked at $65 in Q4 2022.
78 funds tracked by Wall St. Rank held Ocugen as of Q3 2023.

Based on NewSquare Capital's 13F filing for Q3 2023, filed 3 Nov 2023.